Latest Epigenetics biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Células madre pluripotentes: una alternativa muy prometedora para el tratamiento del Alzheimer, el Parkinson o el infarto cerebral

by Universidad de Granada

9 years ago
Alzheimer, Parkinson, stem cells

Un equipo internacional de científicos, en el que participa la Universidad de Granada, revela aspectos desconocidos hasta ahora sobre la biología de células madre, que serán fundamentales para la ...

Discovered a cause of intellectual disability and autism

by Universitat de Barcelona

9 years ago
intellectual disability, JMJD1C gene, autism

The study has analysed 215 cases of patients with intellectual disability, autism or Rett Syndrome without a known genetic defect. “The aim was to determine if we were able to find a molecular cause...

Prenatal Exposure to Air Pollution Associated with the Fetal Growth

by Centro de Investigación en Epidemiología Ambiental (CREAL)

9 years ago
Air Pollution, Fetal Growth

Air pollution exposure during pregnancy has been associated with impaired fetal growth. However, few studies have measured fetal biometry longitudinally, remaining unclear as to whether there are wind...

Understanding the molecular origin of epigenetic markers

by IRB Barcelona - Instituto de Investigación Biomédica

9 years ago
epigenetic markers, gene expression

Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression

Identificados tres genes que abren nuevas vías para el tratamiento del síndrome ICF

by Instituto de Investigación Sanitaria La Fe

9 years ago
DNMT3B, ICF syndrome

Los pacientes con ICF poseen un epigenoma defectuoso que provoca la fragilidad de sus cromosomas, de forma que se pueden romper fácilmente. El estudio confirmó que estos enfermos poseen un control e...

Cancer, blindness, rare diseases and artificial intelligence make Barcelona the world capital for scientific debate with B·Debate 2016

by Biocat

9 years ago
B·Debate, Biocat, Obra Social “La Caixa”

The challenges in fighting blindness, epigenetics and cancer, diagnosing and treating rare diseases, the impact of childhood experiences on adult mental health, and the possibilities of artificial int...

The Pregnancy Exposome, understanding in-utero multiple exposures

by Centro de Investigación en Epidemiología Ambiental (CREAL)

9 years ago
exposome, Pregnancy

Up to now, the environment and child health field has almost uniquely focused on single exposure-health effect relationships; there is no global view of how various types of exposures co-exist and joi...

New clues on the genetic basis of myocardial infarction

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

9 years ago
CARDIoGRAMplusC4D Consortium, coronary artery disease, myocardial infarction

The CARDIoGRAMplusC4D Consortium, an international project in which researchers from the IMIM (Hospital del Mar Medial Research Institute) participated as the only Spanish participants, has identified...

Shaking up the fundamentals of epigenetics

by Universitat de Barcelona

9 years ago
epigenetics

The results of the study —featured on the cover of the October issue of the journal Nature Genetics— contrast sharply with the generally accepted view of the key roles that these epigenetic marks ...

Nueva diana terapéutica para tratar el linfoma cutáneo más prevalente

by Instituto de Investigación Sanitaria La Fe

9 years ago
micosis fungoide, molécula miR-200C

Los investigadores recogieron muestras de piel de pacientes con micosis fungoide en fase tumoral que permitieron identificar la molécula miR-200C como una posible diana terapéutica para diseñar fut...

Queen or worker? Flexibility between roles relies on just a few genes

by Centre for Genomic Regulation

9 years ago
molecular mechanisms, social insects, paper wasps, dinosaur ants, roles

The work illustrates the relevance of genomic approaches, including genome and transcriptome sequencing, to understand animal behaviour. They help to uncover the genetic basis underlying behavioural t...

Oryzon raises $ 19 Million in Private Placement to Advance Therapeutic Programs

by Oryzon Genomics

9 years ago
Oryzon, Najeti, Active Motif, Costex, Corporación Sant Bernat SCR, Grupo Ferrer Internacional, Fondo Capital MAB, Institut Català de Finances (ICF)

Carlos Buesa, Oryzon’s Co-Founder, President and Chief Executive Officer commented, " The success of this capital raise is affirmation that investors , some of them specialized in the epigenetics fi...